Deciphering neuronal deficit and protein profile changes in human brain organoids from patients with creatine transporter deficiency
暂无分享,去创建一个
R. Hamoudi | J. Armengaud | Á. Apáti | B. Sarkadi | N. Costa | A. Maïza | F. Yates | A. Mabondzo | Clémence Disdier | M. Skelton | Rania Harati | O. Mózner | Léa Broca-Brisson | Anne-Cécile Guyot | Romane Gaston-Breton | Lucie Madrange
[1] O. Braissant,et al. Current and potential new treatment strategies for creatine deficiency syndromes. , 2021, Molecular genetics and metabolism.
[2] C. Sandi,et al. Creatine transporter–deficient rat model shows motor dysfunction, cerebellar alterations, and muscle creatine deficiency without muscle atrophy , 2021, bioRxiv.
[3] H. H. Zhang,et al. Creatine transporter deficiency impairs stress adaptation and brain energetics homeostasis , 2021, JCI insight.
[4] Mingyan Lin,et al. DSCAM/PAK1 pathway suppression reverses neurogenesis deficits in iPSC-derived cerebral organoids from patients with Down syndrome , 2021, Journal of Clinical Investigation.
[5] H. Harati,et al. Deciphering the roles of glycogen synthase kinase 3 (GSK3) in the treatment of autism spectrum disorder and related syndromes , 2021, Molecular Biology Reports.
[6] H. Eldar-Finkelman,et al. Mechanisms and Therapeutic Implications of GSK-3 in Treating Neurodegeneration , 2021, Cells.
[7] R. Hamoudi,et al. M1 Polarization Markers Are Upregulated in Basal-Like Breast Cancer Molecular Subtype and Associated With Favorable Patient Outcome , 2020, Frontiers in Immunology.
[8] M. Freissmuth,et al. The Creatine Transporter Unfolded: A Knotty Premise in the Cerebral Creatine Deficiency Syndrome , 2020, Frontiers in Synaptic Neuroscience.
[9] A. Becchetti,et al. An early Sox2-dependent gene expression programme required for hippocampal dentate gyrus development , 2020, bioRxiv.
[10] Stephen J. Bruce,et al. A new rat model of creatine transporter deficiency reveals behavioral disorder and altered brain metabolism , 2020, Scientific Reports.
[11] D. Biard,et al. Long Term Gene Expression in Human Induced Pluripotent Stem Cells and Cerebral Organoids to Model a Neurodegenerative Disease , 2020, Frontiers in Cellular Neuroscience.
[12] Y. Hérault,et al. A Small Compound Targeting Prohibitin with Potential Interest for Cognitive Deficit Rescue in Aging mice and Tau Pathology Treatment , 2020, Scientific Reports.
[13] O. Langer,et al. Proof-of-Concept Study of Drug Brain Permeability Between in Vivo Human Brain and an in Vitro iPSCs-Human Blood-Brain Barrier Model , 2019, Scientific Reports.
[14] B. Alpha-Bazin,et al. Evaluation of Sample Preparation Methods for Fast Proteotyping of Microorganisms by Tandem Mass Spectrometry , 2019, Front. Microbiol..
[15] Marla K. Perna,et al. Deletion of the creatine transporter gene in neonatal, but not adult, mice leads to cognitive deficits , 2019, Journal of inherited metabolic disease.
[16] J. Benoit,et al. Dodecyl creatine ester-loaded nanoemulsion as a promising therapy for creatine transporter deficiency. , 2019, Nanomedicine.
[17] J. Mikol,et al. Small-molecule induction of Aβ-42 peptide production in human cerebral organoids to model Alzheimer's disease associated phenotypes , 2018, PloS one.
[18] R. Hevner,et al. GSK3β Inhibition Restores Impaired Neurogenesis in Preterm Neonates With Intraventricular Hemorrhage. , 2018, Cerebral cortex.
[19] K. Õunap,et al. Treatment outcome of creatine transporter deficiency: international retrospective cohort study , 2018, Metabolic Brain Disease.
[20] Maria K. Jaakkola,et al. ROTS: An R package for reproducibility-optimized statistical testing , 2017, PLoS Comput. Biol..
[21] T. Wieland,et al. De novo microdeletions and point mutations affecting SOX2 in three individuals with intellectual disability but without major eye malformations , 2017, American journal of medical genetics. Part A.
[22] J. Armengaud,et al. RNA-binding proteins are a major target of silica nanoparticles in cell extracts , 2016, Nanotoxicology.
[23] Andrew D. Rouillard,et al. Enrichr: a comprehensive gene set enrichment analysis web server 2016 update , 2016, Nucleic Acids Res..
[24] J. Ávila,et al. GSK3β Overexpression in Dentate Gyrus Neural Precursor Cells Expands the Progenitor Pool and Enhances Memory Skills* , 2016, The Journal of Biological Chemistry.
[25] David J. Price,et al. Regulation of cerebral cortical neurogenesis by the Pax6 transcription factor , 2015, Front. Cell. Neurosci..
[26] G. Cioni,et al. A novel mouse model of creatine transporter deficiency , 2014, F1000Research.
[27] Madeline A. Lancaster,et al. Generation of cerebral organoids from human pluripotent stem cells , 2014, Nature Protocols.
[28] G. Mancini,et al. X-linked creatine transporter deficiency: clinical aspects and pathophysiology , 2014, Journal of Inherited Metabolic Disease.
[29] J. Armengaud,et al. Proteogenomic insights into salt tolerance by a halotolerant alpha-proteobacterium isolated from an Andean saline spring. , 2014, Journal of proteomics.
[30] Madeline A. Lancaster,et al. Cerebral organoids model human brain development and microcephaly , 2013, Nature.
[31] Chun-Teng Huang,et al. SOX2–LIN28/let-7 pathway regulates proliferation and neurogenesis in neural precursors , 2013, Proceedings of the National Academy of Sciences.
[32] P. de Lonlay,et al. Synthesis and biological evaluation of new creatine fatty esters revealed dodecyl creatine ester as a promising drug candidate for the treatment of the creatine transporter deficiency. , 2013, Journal of medicinal chemistry.
[33] E. Chen,et al. Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool , 2013, BMC Bioinformatics.
[34] A. Munnich,et al. Functional and electrophysiological characterization of four non-truncating mutations responsible for creatine transporter (SLC6A8) deficiency syndrome , 2013, Journal of Inherited Metabolic Disease.
[35] Jesús Avila,et al. GSK3 and tau: two convergence points in Alzheimer's disease. , 2012, Journal of Alzheimer's disease : JAD.
[36] E. Tortosa,et al. Microtubule-associated Protein 1B (MAP1B) Is Required for Dendritic Spine Development and Synaptic Maturation , 2011, The Journal of Biological Chemistry.
[37] Joseph F. Clark,et al. Creatine Transporter (CrT; Slc6a8) Knockout Mice as a Model of Human CrT Deficiency , 2011, PloS one.
[38] K. Maclennan,et al. Differential expression of NF-κB target genes in MALT lymphoma with and without chromosome translocation: insights into molecular mechanism , 2010, Leukemia.
[39] Eun-Mi Hur,et al. GSK3 signalling in neural development , 2010, Nature Reviews Neuroscience.
[40] B. Doble,et al. GSK-3 is a master regulator of neural progenitor homeostasis , 2009, Nature Neuroscience.
[41] Boris Jerchow,et al. Molecular evolution of a novel hyperactive Sleeping Beauty transposase enables robust stable gene transfer in vertebrates , 2009, Nature Genetics.
[42] Piotr Fryzlewicz,et al. Data and text mining Variance stabilization and normalization for one-color microarray data using a data-driven multiscale approach , 2006 .
[43] Charles E. Schwartz,et al. X-linked creatine transporter (SLC6A8) mutations in about 1% of males with mental retardation of unknown etiology , 2006, Human Genetics.
[44] Pablo Tamayo,et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[45] C. Schwartz,et al. X-linked creatine transporter defect: An overview , 2003, Journal of Inherited Metabolic Disease.
[46] W. Ball,et al. The clinical syndrome of creatine transporter deficiency , 2003, Molecular and Cellular Biochemistry.
[47] Masahiko Watanabe,et al. The Blood–Brain Barrier Creatine Transporter is a Major Pathway for Supplying Creatine to the Brain , 2002, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[48] B. Wong,et al. Irreversible brain creatine deficiency with elevated serum and urine creatine: A creatine transporter defect? , 2001, Annals of neurology.
[49] J. Benoit,et al. Dodecyl creatine ester and lipid nanocapsule: a double strategy for the treatment of creatine transporter deficiency. , 2015, Nanomedicine.
[50] S. Stockler,et al. Cerebral creatine deficiency syndromes: clinical aspects, treatment and pathophysiology. , 2007, Sub-cellular biochemistry.